No takes yet. Share an insight, caveat, or question.
Computational validation demonstrates flowClean effectively flags acquisition anomalies across flow cytometry datasets, suggesting improved quality control for high-throughput experiments.
Fletez‐Brant et al. (2016) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: